News

As part of the deal, Hapten received a one-time upfront cash payment of $100,000 and 200,000 shares of RXi common stock. Hapten will also be eligible to receive

Nocdurna (desmopressin orally disintegrating tablets) is an antidiuretic that contains desmopressin, a structural analogue of the natural pituitary hormone arginine vasopressin. The drug works by stimulating vasopressin receptors

Cytune is focused on researching and developing new therapies for immune modulation aimed to improve immune response of patients suffering from cancer and infectious diseases. PPF Group shareholder

The data show that topical application of AKP-11 was safe, well-tolerated as well as resulted in a significant reduction in plaque severity. The company said that no detectable

"In mid-2013 we announced that we had received notification that our patent and trademarks for the Nyloxin® line of pain relievers had been published in India’s Official Journal,

The agreement will strengthen AstraZeneca’s aclidinium respiratory franchise and is expected to add immediate revenues with long-term growth potential. Upon completion of the transaction, AstraZeneca will own the

Valued at $90 per Hospira share, the acquisition is expected to improve Pfizer’s Global Established Pharmaceutical (GEP) Business as well as strengthen its portfolio of generic injectable drugs

The patented cotton enhanced insulating materials used in all the packaging products offer soft cushioning thermal protection. The packaging, post-use, is disposable by the customer as ordinary household

As part of the deal, the two parties will focus on preclinical research involving QR Pharma’s lead drug candidate Posiphen. The deal will see investigators at Rockefeller conduct